These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

694 related items for PubMed ID: 25117162

  • 1. Emergence of chemoresistance in a metastatic basal cell carcinoma patient after complete response to hedgehog pathway inhibitor vismodegib (GDC-0449).
    Meani RE, Lim SW, Chang AL, Kelly JW.
    Australas J Dermatol; 2014 Aug; 55(3):218-21. PubMed ID: 25117162
    [Abstract] [Full Text] [Related]

  • 2. Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib.
    Chang AL, Solomon JA, Hainsworth JD, Goldberg L, McKenna E, Day BM, Chen DM, Weiss GJ.
    J Am Acad Dermatol; 2014 Jan; 70(1):60-9. PubMed ID: 24189279
    [Abstract] [Full Text] [Related]

  • 3. Vismodegib: an inhibitor of the Hedgehog signaling pathway in the treatment of basal cell carcinoma.
    Proctor AE, Thompson LA, O'Bryant CL.
    Ann Pharmacother; 2014 Jan; 48(1):99-106. PubMed ID: 24259609
    [Abstract] [Full Text] [Related]

  • 4. Vismodegib for the treatment of basal cell carcinoma: results and implications of the ERIVANCE BCC trial.
    Dessinioti C, Plaka M, Stratigos AJ.
    Future Oncol; 2014 May; 10(6):927-36. PubMed ID: 24941979
    [Abstract] [Full Text] [Related]

  • 5. Vismodegib: a guide to its use in locally advanced or metastatic basal cell carcinoma.
    Lyseng-Williamson KA, Keating GM.
    Am J Clin Dermatol; 2013 Feb; 14(1):61-4. PubMed ID: 23329081
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vismodegib: a hedgehog pathway inhibitor for locally advanced and metastatic basal cell carcinomas.
    Sobanko JF, Okman J, Miller C.
    J Drugs Dermatol; 2013 Oct; 12(10 Suppl):s154-5. PubMed ID: 24085062
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vismodegib.
    Meiss F, Zeiser R.
    Recent Results Cancer Res; 2014 Oct; 201():405-17. PubMed ID: 24756807
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma.
    Cirrone F, Harris CS.
    Clin Ther; 2012 Oct; 34(10):2039-50. PubMed ID: 23036338
    [Abstract] [Full Text] [Related]

  • 13. Vismodegib in the treatment of advanced BCC.
    O'Kane GM, Lyons T, McDonald I, Mulligan N, Moloney FJ, Murray D, Kelly CM.
    Ir Med J; 2014 Oct; 107(7):215-6. PubMed ID: 25226719
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study.
    Sekulic A, Migden MR, Basset-Seguin N, Garbe C, Gesierich A, Lao CD, Miller C, Mortier L, Murrell DF, Hamid O, Quevedo JF, Hou J, McKenna E, Dimier N, Williams S, Schadendorf D, Hauschild A, ERIVANCE BCC Investigators.
    BMC Cancer; 2017 May 16; 17(1):332. PubMed ID: 28511673
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Vismodegib in metastasized basal cell carcinoma].
    Reinders MG, Dirix L, Mosterd K, van Doorn R.
    Ned Tijdschr Geneeskd; 2013 May 16; 157(12):A6011. PubMed ID: 23515044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.